13D Filing: OrbiMed Advisors and Viewray Inc. (VRAY)

Page 2 of 10 – SEC Filing

CUSIP No. 92672L107
1
NAME OF REPORTING PERSON

OrbiMed Advisors LLC
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ☐
(b) ☐
3
SEC USE ONLY
4
SOURCE OF FUNDS

AF
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
6
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF SHARES
BENEFICIALLY OWNED
BY EACH REPORTING
PERSON WITH
7
SOLE VOTING POWER
                       
0
8
SHARED VOTING POWER
                   
9,866,102(1)
9
SOLE DISPOSITIVE POWER
                         
0
10
SHARED DISPOSITIVE POWER
                         
9,866,102(1)
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
                                  
9,866,102(1)
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13.13% (2)
14
TYPE OF REPORTING PERSON (See Instructions)

IA
(1)
Includes (i) 9,458,567 outstanding shares of common stock, par value $0.01 per share (the “Shares”), of ViewRay, Inc., a Delaware corporation (the “Issuer”), and (ii) 407,535 Shares issuable upon the exercise of warrants to purchase shares (the “Warrants”).
(2)
This percentage is calculated based upon 74,744,555 Shares outstanding of the Issuer, as set forth in the Issuer’s Prospectus Supplement, filed with the Securities and Exchange Commission on February 27, 2018, and includes an additional 407,535 Shares subject to currently exercisable Warrants held by the Reporting Persons.
Follow Viewray Inc. (NASDAQ:VRAY)